NEOADJUVANT CHEMOIMMUNOTHERAPY

Clinical trials for NEOADJUVANT CHEMOIMMUNOTHERAPY explained in plain language.

Never miss a new study

Get alerted when new NEOADJUVANT CHEMOIMMUNOTHERAPY trials appear

Sign up with your email to follow new studies for NEOADJUVANT CHEMOIMMUNOTHERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1

New combo aims to shrink rectal tumors, spare patients from radiation

Disease control Ongoing

This study is testing a combination of two chemotherapy drugs plus an immunotherapy drug (sintilimab) given before surgery for locally advanced rectal cancer. The goal is to see if this approach can effectively shrink tumors and achieve a good response, potentially allowing some …

Matched conditions: NEOADJUVANT CHEMOIMMUNOTHERAPY

Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Anhui Medical University • Aim: Disease control

Last updated Apr 02, 2026 03:41 UTC

NEOADJUVANT CHEMOIMMUNOTHERAPY

Get alerted when new NEOADJUVANT CHEMOIMMUNOTHERAPY trials appear

New combo aims to shrink rectal tumors, spare patients from radiation